At OrphAI Therapeutics, we are focused on identifying and developing innovative therapeutics. Our current clinical stage drug candidates target Group 1 and Group 3 Pulmonary Hypertension and bronchiolitis obliterans syndrome post lung transplant.
Company Details
- Employees
- 12
- Founded
- -
- Address
- 101 College Street, New Haven,06510,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- clinical development, molecular and cell biology, pulmonary hypertension, bronchiolitis obliterans syndrome post lung transplant.
- HQ
- New Haven
Orphai Therapeutics Questions
Orphai Therapeutics's website is https://www.orphai-therapeutics.com
Orphai Therapeutics's LinkedIn profile is https://www.linkedin.com/company/orphaitherapeutics
Orphai Therapeutics has
12 employees.
View email and phone details for 12
employees at Orphai Therapeutics.
Orphai Therapeutics's industry is
Biotechnology Research
Orphai Therapeutics's top competitors are
Hyperfine | Ai-Powered Portable Mri,
Identifeye Health,
Neurocentria, Inc.,
Detect,
Butterfly Network, Inc.,
Denali Therapeutics,
4catalyzer,
Turquoise Health,
Quantum-Si,
Neurocrine Biosciences.
Orphai Therapeutics's categories are Biotechnology Research
Orphai Therapeutics's founding year is 2013
